About

Amir S. Naderi, MD

Board-certified internist and nephrologist working at the intersection of kidney disease and obesity medicine — the editor of Nephrobesity.

Dr. Naderi is a board-certified Internist and Nephrologist and a Fellow of the American Society of Nephrology (FASN). His work centres on the obesity–nephrology interface — the cardio-renal-metabolic space where modern incretin pharmacology, chronic kidney disease, and metabolic risk converge. He completed his Internal Medicine residency at the University of Texas Southwestern Medical Center (2005–2008) and his Nephrology fellowship at The Johns Hopkins University Hospital (2008–2010), and holds board certification in Internal Medicine and Nephrology in both the United States and Germany.

His interest in the kidney–obesity axis is long-standing. His doctoral thesis (2003) — the first study of its kind in Germany — examined a fatty-acid-binding-protein (FABP2 Thr54) polymorphism in patients with morbid obesity, work that anticipated much of today’s cardio-renal-metabolic thinking. His clinical practice now integrates evidence-based obesity pharmacotherapy — GLP-1 receptor agonists, dual incretins, and emerging multi-agonist therapies — with the management of chronic kidney disease, hypertension, and cardiometabolic risk.

He is the founder and medical director of a physician-led internal medicine, nephrology, and obesity medicine practice in Hamburg, Germany, and has previously served as medical director of an outpatient dialysis unit. He is an appointed examiner for the specialist board examinations of the Hamburg Medical Association and a recipient of a Teaching Excellence Award for his clinical instruction.

Nephrobesity grew out of that clinical and academic work. It exists to give nephrologists, endocrinologists, and internists a source-bound reference for a field that is still taking shape.

Credentials

• Board certification — American Board of Internal Medicine: Internal Medicine and Nephrology; German Medical Board: Internal Medicine and Nephrology
• Fellow of the American Society of Nephrology (FASN)
• Certified Hypertension Specialist (Germany)
• Training — Internal Medicine, UT Southwestern Medical Center (Dallas); Nephrology, The Johns Hopkins University Hospital (Baltimore)
• Active U.S. (Texas) and German medical licensure
• Member — American College of Physicians, American Society of Nephrology, Obesity Medicine Association, The Obesity Society

Selected publications

• Alizadeh Naderi AS, Reilly RF. Hereditary disorders of renal phosphate wasting. Nat Rev Nephrol. 2010;6(11):657–665.
• Naderi AS, Reilly RF. Hereditary etiologies of hypomagnesemia. Nat Clin Pract Nephrol. 2008;4(2):80–89.
• Naderi AS, Reilly RF. Primary care approach to proteinuria. J Am Board Fam Med. 2008;21(6):569–574.
• Naderi AS, Reilly RF. The Patient with Kidney Stones. In: Schrier RW, ed. Manual of Nephrology, 7th ed.

Selected; full publication list available on request.

Contact

For academic correspondence: info@dr-naderi.de